Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06744465 | NearWave Optical Molecular Monitoring | recruiting | N/A | 15 | Indiana UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06906601 | Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.(MAGNETO) | recruiting | — | 772 | Centre Leon BerardOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07145255 |
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors |
| recruiting |
| Phase 1 / Phase 2 |
| 150 |
| MBrace TherapeuticsINDUSTRY |
| 1 |
| Feb 17, 2026 |
| clinicaltrials |
| NCT07244094 | A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps(ARGUS project) | recruiting | — | 400 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation(GUARDIAN-101) | recruiting | Phase 1 | 90 | Clasp Therapeutics, Inc.INDUSTRY | 1 | Feb 13, 2026 | clinicaltrials |
| NCT04265872 | Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC | recruiting | Early Phase 1 | 20 | Baylor Research InstituteOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06517212 | Tirzepatide Weight Loss for MRD+ Early Breast Cancer(TRIM-EBC) | recruiting | Phase 2 | 48 | Baylor Research InstituteOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07071038 | Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients(SWIVEL) | recruiting | Phase 2 | 62 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07208149 | A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC) | recruiting | Phase 1 / Phase 2 | 42 | Shenzhen Majory Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07281976 | A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer | recruiting | Phase 1 / Phase 2 | 220 | Nanjing Leads Biolabs Co.,LtdINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07405931 | Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients | recruiting | N/A | 414 | Ulsan University HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07407153 | Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device(Ultra-3 CBE) | recruiting | N/A | 600 | International Agency for Research on CancerOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07407439 | Real-world Studies of CDK4/6 Inhibitors | recruiting | — | 245 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06135714 | Metastasis-directed Therapy for Oligometastases of Breast Cancer(OLIGAMI) | recruiting | Phase 3 | 340 | Tokyo Medical and Dental UniversityOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06610565 | Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer | recruiting | N/A | 60 | European Institute of OncologyOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07188246 | Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer(BRINK) | recruiting | Phase 2 | 40 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07206121 | Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery | recruiting | N/A | 10 | Innoblative Designs, Inc.INDUSTRY | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07376538 | Response-Based Local Therapy for Regionally Advanced Breast Cancer | recruiting | Phase 2 | 157 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07397585 | stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database(ORIETTA) | recruiting | — | 300 | Istituto Clinico HumanitasOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06064812 | A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. | recruiting | Phase 1 / Phase 2 | 99 | Forward Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 10, 2026 | clinicaltrials |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer | recruiting | Phase 3 | 550 | Jazz PharmaceuticalsINDUSTRY | 15 | Feb 10, 2026 | clinicaltrials |
| NCT07233928 | Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers(ESPRESSOBREAST) | recruiting | N/A | 1,050 | Institut Claudius RegaudOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07390448 | Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy Surgeries | recruiting | N/A | 40 | National Cancer Institute, EgyptOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07399808 | CDK4/6 Inhibitors in Breast Cancer Elderly Patients: an Observational Ambispective Longitudinal Multicenter Study | recruiting | — | 100 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07401537 | Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer | recruiting | Phase 2 | 416 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT04368702 | CONFIRM: Magnetic Resonance Guided Radiation Therapy(CONFIRM) | recruiting | N/A | 70 | Brigham and Women's HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT03740256 | Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors(VISTA) | recruiting | Phase 1 | 45 | Baylor College of MedicineOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07042581 | A Study of Revaree Plus in People With Breast Cancer | recruiting | Phase 4 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07394218 | ctDNA-guided Treatment Decision-making | recruiting | Phase 2 | 122 | Fudan UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04916990 | Improving Care for Rural Patients With Solid Tumors | recruiting | N/A | 320 | University of Colorado, DenverOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05126290 | CTNNA1 Familial Expansion Study(CAFÉ) | recruiting | — | 100 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05504707 | DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer(DecipHER) | recruiting | Phase 1 | 30 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05684367 | Exercise to ReGain Stamina and Energy (The EXERGISE Study) | recruiting | N/A | 24 | University of FloridaOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06265558 | Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery(TPN-SEIN) | recruiting | N/A | 254 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07001241 | Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors | recruiting | Phase 2 | 134 | University of Colorado, DenverOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07018986 | The MIND-BC Study: MIND Diet for Breast Cancer Cognition(MIND-BC) | recruiting | N/A | 200 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07236177 | B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.(B-GLUCANCER2) | recruiting | Early Phase 1 | 220 | Poitiers University HospitalOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07389408 | A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing(PRELUDE) | recruiting | — | 2,000 | National and Kapodistrian University of AthensOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07389967 | Nutrition Awareness Among Women With Non-Metastatic Breast Cancer | recruiting | N/A | 200 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07390838 | A Study of SH009 Injection in Patients With Advanced Solid Tumors. | recruiting | Phase 1 | 150 | Nanjing Sanhome Pharmaceutical, Co., Ltd.INDUSTRY | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06115486 | EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer | recruiting | N/A | 30 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06739655 | Preoperative Radiation Therapy and Immediate Breast Reconstruction(PRADAIIBE) | recruiting | N/A | 180 | Cancer Research AntwerpOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03017573 | Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)(SCANDARE) | recruiting | N/A | 1,050 | Institut CurieOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04799535 | Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring | recruiting | — | 550 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT05360290 | CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial(CTCNeoBC-E) | recruiting | N/A | 484 | RenJi HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06301438 | Dalpiciclib in HR+/HER2- ABC | recruiting | — | 103 | RenJi HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06858449 | Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer(NeoChemoPRT) | recruiting | N/A | 30 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07087691 | Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance | recruiting | N/A | 60 | University of California, San DiegoOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07367269 | Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy | recruiting | N/A | 60 | Artvin Coruh UniversityOTHER | 1 | Feb 3, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Feb 17, 2026source: clinicaltrials